51 Recruiting Metastatic Castration-resistant Prostate Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Metastatic Castration-resistant Prostate Cancer
Related Conditions
Top Recruiting Metastatic Castration-resistant Prostate Cancer Studies
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
📍 Helen Diller Family Comprehensive Cancer Center University of California San Francisco — San Francisco, California
View Study & Checklist ➔Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment
📍 Arizona Institute of Urology (AIU) - Tucson — Tucson, Arizona
View Study & Checklist ➔ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
📍 UC Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope /ID# 262059 — Duarte, California
View Study & Checklist ➔FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
📍 City of Hope - Duarte Cancer Center — Duarte, California
View Study & Checklist ➔Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
📍 Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
📍 University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
📍 Stanford University Medical Center - Blake Wilbur Drive — Palo Alto, California
View Study & Checklist ➔A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
📍 University of California LA — Los Angeles, California
View Study & Checklist ➔A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
📍 University of California San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
📍 City of Hope Cancer Center Phoenix — Goodyear, Arizona
View Study & Checklist ➔Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
📍 Excel Diagnostics & Nuclear Oncology Center — Houston, Texas
View Study & Checklist ➔Study With [225Ac]Ac-FL-020 in mCRPC Participants
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
📍 Research Site — Dothan, Alabama
View Study & Checklist ➔Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
View Study & Checklist ➔A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
📍 Western Regional Medical Center - City of Hope Phoenix Goodyear — Goodyear, Arizona
View Study & Checklist ➔A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
📍 Rocky Mountain Cancer Centers — Aurora, Colorado
View Study & Checklist ➔The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
📍 Chao Family Comprehensive Cancer Centre — Orange, California
View Study & Checklist ➔ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
📍 California Research Institute — Los Angeles, California
View Study & Checklist ➔A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 VA West Los Angeles Medical Center - (CRS) - NAVREF - PPDS — Los Angeles, California
View Study & Checklist ➔A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Research Site — Palo Alto, California
View Study & Checklist ➔Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
📍 Central Alabama Research — Birmingham, Alabama
View Study & Checklist ➔